Correlation Between Cumberland Pharmaceuticals and Codexis
Can any of the company-specific risk be diversified away by investing in both Cumberland Pharmaceuticals and Codexis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cumberland Pharmaceuticals and Codexis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cumberland Pharmaceuticals and Codexis, you can compare the effects of market volatilities on Cumberland Pharmaceuticals and Codexis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cumberland Pharmaceuticals with a short position of Codexis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cumberland Pharmaceuticals and Codexis.
Diversification Opportunities for Cumberland Pharmaceuticals and Codexis
-0.49 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Cumberland and Codexis is -0.49. Overlapping area represents the amount of risk that can be diversified away by holding Cumberland Pharmaceuticals and Codexis in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Codexis and Cumberland Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cumberland Pharmaceuticals are associated (or correlated) with Codexis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Codexis has no effect on the direction of Cumberland Pharmaceuticals i.e., Cumberland Pharmaceuticals and Codexis go up and down completely randomly.
Pair Corralation between Cumberland Pharmaceuticals and Codexis
Given the investment horizon of 90 days Cumberland Pharmaceuticals is expected to under-perform the Codexis. But the stock apears to be less risky and, when comparing its historical volatility, Cumberland Pharmaceuticals is 1.01 times less risky than Codexis. The stock trades about -0.02 of its potential returns per unit of risk. The Codexis is currently generating about 0.24 of returns per unit of risk over similar time horizon. If you would invest 262.00 in Codexis on September 7, 2024 and sell it today you would earn a total of 201.00 from holding Codexis or generate 76.72% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 98.44% |
Values | Daily Returns |
Cumberland Pharmaceuticals vs. Codexis
Performance |
Timeline |
Cumberland Pharmaceuticals |
Codexis |
Cumberland Pharmaceuticals and Codexis Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Cumberland Pharmaceuticals and Codexis
The main advantage of trading using opposite Cumberland Pharmaceuticals and Codexis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cumberland Pharmaceuticals position performs unexpectedly, Codexis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Codexis will offset losses from the drop in Codexis' long position.Cumberland Pharmaceuticals vs. Akanda Corp | Cumberland Pharmaceuticals vs. Knife River | Cumberland Pharmaceuticals vs. Saat Servative Strategy | Cumberland Pharmaceuticals vs. SEI Investments |
Codexis vs. Nuvation Bio | Codexis vs. Lyell Immunopharma | Codexis vs. Century Therapeutics | Codexis vs. Generation Bio Co |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |